UMEM Educational Pearls

Category: Orthopedics

Title: Cognitive rest following concussion

Keywords: head injury, concussion, return to play, cognitive rest (PubMed Search)

Posted: 2/23/2013 by Brian Corwell, MD
Click here to contact Brian Corwell, MD

Just before you upgraded your old computer, recall what happened when you had Excel, Word and PowerPoint all open at the same time. In the concussed state, the brain is essenatially functioning like your old computer... and the more tasks it must perform, the slower it will work and slower it will recover. Hence the concept of cognitive rest. Below is taken from the AMSSM position statement of concussion in sport.

 

Return to school

There are no standardized guidelines for returning the injured athlete to school. If the athlete develops increased symptoms with cognitive stress, student athletes may require academic accommodations such as a reduced workload, extended test-taking time, days off or a shortened school day.

Some athletes have persistent neurocognitive deficits following a concussion, despite being symptom free. Consideration should be made to withhold an athlete from contact sports if they have not returned to their ‘academic baseline’ following their concussion (level of evidence C).

The CDC developed educational materials for educators and school administrators that are available at no cost and can be obtained via the CDC website. Additional resources for academic accommodations should be developed for both clinicians and educators (level of evidence C).

Adam Friedlander shared the practical application of this which I found amusing:

" I always recommend what Peds neuro called "a brain holiday" - my favorite part.  All of our nurses look at me like I'm nuts, but it is now on our official concussion/CHI DC instructions.  I always say to the kiddo: "You'll love this part.  No homework, no reading."  Then I turn to mom and dad and tell them they'll love the next part: "No TV, no video games."

Thank you for sharing Adam!!

Show References



Management of the patient with intracranial hypertension represents one of the most challenging situations the emergency physician faces. Doing so in a community setting when the patient is a child is even more daunting. But devising therapies that can safely be given while the patient is being transferred to a tertiary center for definitive therapy is truly cringe-inducing. 
 
Fortunately, a recent study suggests that 3% saline fits this bill nicely. Given the risk of vasconstriction with hyperventilation and the risk of hypovolemia with mannitol, hypertonic saline has gained has emerged as beneficial therapy when trying to decrease intracranial pressure (ICP) in both children and adults. 
 
In late 2011, the Loma Linda University Medical Center published a retrospective analysis of their experience using 3% saline during transport of children at risk of elevated ICPs. While they found the expected rise in electrolytes such as sodium, chloride and bicarbonate, importantly they found no adverse effects (such as "local effects, renal abnormalities or central pontine myelinolysis") related to the administration of hypertonic saline, even though 96% of patients received the infusion through a peripheral line.
 
Bottom line: hypertonic saline appears to be a viable and safe option for use as therapy to decrease ICH during transport of children at risk for intracranial hypertension.
 
 
Reference:

Luu JL, Wendtland CL, Gross MF, et al. Three percent saline administration during pediatric critical care transport. Ped Emerg Care 2011;27(12):1113-1117



Typical opioid withdrawal include clinical symtpoms of piloerection, nausea, vomiting and diarrhea. If you were to see seizure, another etiology other than opioid withdrawal should be investigated. 

Except in the case of neonates borne to women who have been taking opioids chronically such as a methodone patient. Once the child is born, symptoms of withdrawal may take days to weeks to materialize though seizures typically occur <10 days. The child is at increased risk of SIDS as well.



Category: International EM

Title: Japanese Encephalitis

Keywords: japanese encephalitis, international, virus, infectious disease (PubMed Search)

Posted: 2/20/2013 by Andrea Tenner, MD (Updated: 5/4/2024)
Click here to contact Andrea Tenner, MD

Japanese Encephalitis

 
General Information:
     – caused by Japanese encephalitis virus (JEV), closely related to West Nile virus    
     – transmission is through infected mosquito
     – most common cause of vaccine-preventable cause of encephalitis in Asia
     – Incubation period is 5-15 days
     – <1% develop clinical, disease, most asymptomatic
     – Acute encephalitis most common presentation 
     – Sx: altered mental status, focal neuro deficits, movement disorder, seizure, fever, headache,    
         vomiting
     – Classic presentation: Parkinsonian syndrome with mask-like facies, tremor, cogwheel rigidity, and
        choreoathtoid movements
     – case-fatality is 20-30%
 
Area of the world affected:
     -- Primarily in Asia – China, Japan, Korea, India, Southeast Asia
 
Relevance to the US physician:
1. JE
      -- Should be considered in patients concerned for neurological infection with recent travel to
          endemic country
      -- Lab: JEV-specific IgM in serum (after 7 days of sx onset) or CSF (after 4 days of sx onset)
      -- Viral culture and other viral RNA amplifications tests are not sensitive
      -- Treatment is supportive
      -- In survivors, 30-50% have significant neurological/cognitive/psychological sequelae
2. Vaccine
      -- One vaccine (Ixiaro) is available in the US    
      -- 2 doses, 28 days apart (96% develop immunity)
      -- No information on duration of protection
      -- Recommended for travelers ≥ 1 month in endemic areas during JEV season
 
Bottom Line:
Very rare but deadly disease with high mortality and post-infection sequelae.  Think about it in travelers to Asia during summer/fall seasons who have not been immunized.
 
University of Maryland Section of Global Emergency Health
Author:  Veronica Pei
 

Show References



Managing Traumatic Hemorrhagic Shock

  • When managing the critically ill patient with traumatic hemorrhagic shock, the primary objectives are to stop bleeding, maintain tissue perfusion and oxygen delivery, and limit organ dysfunction.
  • Pearls to consider when resuscitating these patients include:
    • In the patient without brain injury, target an SBP of 80 - 100 mm Hg until major bleeding has been controlled.
    • Limit aggressive fluid resuscitation
    • Avoid delays in blood and blood component transfusion.  Transfuse early. Though the optimal ratio remains controversial, most transfuse PRBCs and FFP in a 1:1 ratio.
    • Consider point-of-care testing, such as thromboelastography (TEG), to assess the degree of coagulopathy and guide transfusion strategies.
    • Consider the use of tranexamic acid

Show References



Question

68 year-old female presents with stridor and palpable goiter. Here's a clip from CT of the chest. What's the diagnosis?

Show Answer

Show References



Category: Cardiology

Title: Transcatheter Aortic-Valve Replacement (TAVR)

Keywords: Transcatheter Aortic-Valve Replacement (TAVR) (PubMed Search)

Posted: 2/17/2013 by Semhar Tewelde, MD
Click here to contact Semhar Tewelde, MD

 

  • Symptomatic aortic stenosis if left untreated has a high mortality rate (5 yr mortality rate is 50% w/angina, 3 yr mortality rate is 50% w/syncope, and 2 yr mortaltiy rate is 50% w/CHF)
  • Standard tx includes medical therapy +/- balloon aortic valvuloplasty
  • A recent study comparing standard therapy to transcatheter aortic-valve replacement (TAVR) revealed rates of death at 2 yrs were 68% in standard therapy group vs. 43.3% in TAVR group (p<0.001)
  • At 2 yrs the rate of rehospitalization was 72.5% in standard therapy group vs. 35% in TAVR group
  • The rate of stroke was higher after TAVR vs. standard therapy in the 1st 30 days
  • In appropriate patients with severe AS who are not surgical candidates TAVR reduced rates of death, hospitalizations, and symptoms at 2 yr follow-up

 

Show References



Category: Toxicology

Title: Antidote Safety in Pregnancy

Keywords: antidote, pregnancy, ethanol, amyl nitrate, methylene blue, penicillamine, lorazepam, diazepam (PubMed Search)

Posted: 2/13/2013 by Bryan Hayes, PharmD (Emailed: 2/14/2013) (Updated: 2/14/2013)
Click here to contact Bryan Hayes, PharmD

Most antidotes have not been adequately studied in pregancy and hold a Pregnancy Risk Category 'C' by the FDA. However, there are a few antidotes that hold a category 'D' or 'X' rating (contraindicated).

  1. Ethanol (toxic alcohols) - Category C
    • Reproduction studies have not been conducted with alcohol injection. Ethanol crosses the placenta, enters the fetal circulation, and has teratogenic effects in humans. When used as an antidote during the second or third trimester, Fetal Alcohol Syndrome AS is not likely to occur due to the short treatment period; use during the first trimester is controversial.
    • Alternative (preferred) antidote: fomepizole.
  2. Methylene blue (methemoglobinemia) - Category X
    • Use during amniocentesis has shown evidence of fetal abnormalities, but it has been used orally without similar adverse events. IV may be ok.
  3. Lorazepam and diazepam (seizures, nerve agents) - Category D
    • Teratogenic effects have been observed in some animal studies and in humans. Lorazepam/diazepam and their metabolite cross the human placenta.
  4. Potassium iodide (radioactive iodine) - Category D
    • Iodide crosses the placenta (may cause hypothyroidism and goiter in fetus/newborn). Use for protection against thyroid cancer secondary to radioactive iodine exposure is considered acceptable based upon risk:benefit, keeping in mind the dose and duration.
  5. Amyl nitrite (cyanide) - Category C (manufacturer contraindicates)
    • Animal reproduction studies have not been conducted. Because amyl nitrate significantly decreases systemic blood pressure and therefore blood flow to the fetus, use is contraindicated in pregnancy (per manufacturer).
    • Other options exist to treat cyanide exposure including sodium nitrite, sodium thiosulfate, and hydroxocobalamin.
  6. Penicillamine (chelator) - Category D

In most cases, the benefits of short-term use probably outweigh the risk, especially when accounting for the health and prognosis of the mother.

Show References



-    The most common disease producing enzymopathy in humans

-    Affects 400 million people worldwide

-    Highest prevalence is among persons of African, Asian, and Mediterranean descent

-    Patients can be asymptomatic but may present with symptoms of acute hemolytic anemia, which may be precipitated by certain medications (Oxidative medications) or foods (some types of beans)

-    Avoid oxidative drugs (consult your PharmD when your patient has G6PDd)

-    Diagnosis: Measure the actual enzyme activity of G6PD rather than the amount of the enzyme. A more practical test is the presence of Indirect hyperbilirubinemia, but it is non specific

-    Treatment consists of oxygen and bed rest in minor cases. However, severe cases may require PRBC transfusion

Show References



Propofol is generally a well-tolerated sedative / amnestic but occasionally it can lead to the propofol infusion syndrome (PRIS); a metabolic disorder causing end-organ dysfunction.

Suspect PRIS in patients with increasing lactate levels, worsening metabolic acidosis, worsening renal function, increased triglyceride levels, or creatinine kinase levels. End-organ effects include:

  • Myocardial dysfunction / Arrhythmias
  • Rhabdomyolysis
  • Acute renal failure

The true incidence of PRIS is unknown, however, certain risk factors have been identified:

  • Doses >4-5mg/kg/hour
  • <18 years of age
  • Critically-ill patients; especially receiving vasopressors or steroids
  • History of mitochondrial disorders
  • Infusions >48 hours

Prevent PRIS by using adequate analgesia (with morphine or fentanyl) post-intubation, which may reduce the overall dosage of propofol ultimately reducing the risk.

If PRIS develops, stop propofol and provide supportive care; IV fluids, ensuring good urine output, adequate oxygenation, dialysis (if indicated), vasopressor and inotropic support.

Show References



Question

A 25 year-old female presents complaining of a "net-like" rash bilaterally on her medial thighs. She denies any pain but states that the rash looks “pretty scary” What's the diagnosis?

Show Answer

Show References



-Common life-threatening cardiovascular effects of cocaine intoxication include tachydysrhythmias, ventricular fibrillation, myocardial ischemia, and infarction.

-Emergency management of acute cocaine intoxication relies mainly on supportive and symptomatic treatment, w/liberal use of gamma-aminobutyric acid receptor agonists such as benzodiazepines.

-Intravenous lipid emulsion (ILE) therapy has been used successfully to treat cardiac toxicity associated with a variety of lipid-soluble drugs, such as local anesthetics, calcium/beta-blockers, tricyclic anti-depressants, and cocaine. 

-The current hypothesis, called the “lipid sink” hypothesis, suggest that ILE infusion creates an expanded lipid phase in the plasma that absorbs the circulating lipophilic toxin and decreases the amount of free unbound toxin available to bind to the myocardium.

-When life-threatening cardiac arrhythmias (e.g. wide-complex tachycardia/prolonged QT) are not amenable to standard therapy (e.g. sodium bicarbonate/magnesium) consider ILE as a potential option to the current algorithm. 

Show References



Category: Orthopedics

Title: Sports-related Concussion

Keywords: head injury, concussion, return to play (PubMed Search)

Posted: 2/9/2013 by Brian Corwell, MD (Updated: 5/4/2024)
Click here to contact Brian Corwell, MD

Estimated 3.8 million sport-related concussions per year (likely significantly higher due to underreporting)

Most patients recover within a 7-10 day period

** Children and teenagers require more time than college and professional athletes

This "accepted" time for recovery is not scientifically established and there is a large degree of variability based on multiple factors including age (as above), sex & history of prior concussions

 

Approximately 10% of athletes have persistent signs and symptoms beyond 2 weeks (which may represent a prolonged concussion or the development of post-concussion syndrome)

During this time the patient should have complete rest from all athletic activities, close follow-up with PCP and be educated re concussions.

If practical, "cognitive rest" should also be prescribed. This is one of the most frequently neglected aspects of post-concussion care and will be discussed in a future pearl.



Category: Toxicology

Title: Clenbuterol

Keywords: anabolic, bodybuilding, weightlifting, beta agonist, myocardial infarction (PubMed Search)

Posted: 2/7/2013 by Ellen Lemkin, MD, PharmD
Click here to contact Ellen Lemkin, MD, PharmD

  • Found as adulterant in street drugs

  • Used in bodybuilding and for weight loss

  • Long acting beta-2 agonist

  • Has specific anabolic activity and increases lipolysis

  • Toxicity presents with tachycardia, palpitations, tremor, and myocardial ischemia



Category: International EM

Title: Clarification: Melioidosis

Keywords: Melioidosis, Burkholderia pseudomallei (PubMed Search)

Posted: 2/7/2013 by Andrea Tenner, MD (Updated: 5/4/2024)
Click here to contact Andrea Tenner, MD

Just a quick clarification to last week's melioidosis pearl:

An astute reader noted the typo:  "The patient should also be covered for melioidosis, and infection caused by Burkholderia pseudomallei."  The sentence should read "...meliodosis, an infection caused by Burkholderia pseudomallei."

Just to clarify, melioidosis is caused by the bacteria Burkholderia pseudomallei.

Many apologies for any confusion this might have caused.

Thanks for reading!

Andi Tenner, MD, MPH



Category: International EM

Title: PPD positive? Good news...

Keywords: Rifapentine, latent tuberculosis, international, infectious disease (PubMed Search)

Posted: 2/6/2013 by Andrea Tenner, MD (Updated: 5/4/2024)
Click here to contact Andrea Tenner, MD

Background Information:

Active tuberculosis (TB) develops in 5-10% of individuals who become infected with M. tuberculosis, typically after a latency period of 6-18 months (but sometimes decades later).  Compliance with the 9 month self-supervised isoniazid (INH) regimen has been porr with completion rates <60%.  Until recently, daily rifampin for 4-6 months has been the only alternative when the bacterium is resistant or INH cannot be used.

Pertinent Study Design and Conclusions:

  • Another rifamycin class antibiotic, Rifapentine (RPT) is approved for MDR-TB but had not been approved for latent TB treatment.
  • Recent RCTs show 12 weekly doses of INH-RPT administered as directly observed therapy (DOT) are efficacious in preventing active disease and are better tolerated.
  • CDC now recommends the 12 week INH-RPT DOT regimen as an equal alternative to 9 months of self supervised daily INH in patients aged >12 years who have a high likelihood of developing active TB.

Bottom LIne:

A substantially shorter course of therapy with INH-RPT is now the recommended treatment for latent TB.

University of Maryland Section of Global Emergency Health

Author: Emilie J. B. Calvello, MD, MPH

Show References



Needle Decompression - Are we Teaching the Right Location?

  • Tension pneumothorax frequently results in circulatory collapse and may lead to cardiopulmonary arrest.
  • In the event that tube thoracostomy cannot be immediately performed, traditional teaching is to perform needle decompression in the second intercostal space, mid-clavicular line using a 5-cm angiocath needle.
  • Recent literature, however, has challenged the traditional location for needle decompression.  In fact, researchers found:
    • Needles placed in the second intercostal space often failed to enter the chest cavity and relieve tension physiology.
    • Needles placed in the fifth intercostal space in the anterior axillary line were more likely to enter the chest cavity with a lower failure rate.
  • Take Home Point: It may be time to reconsider the optimal position for needle decompression of tension pneumothorax.

Show References



Question

40 year-old male presents with fever, chills, & cough. What’s the diagnosis and the MOST likely cause? 

Show Answer

Show References



  • Early CPR performed by laypersons can double the chances of survival in out-of-hospital cardiac arrest (OHCA)
  • A retrospective cohort that combined 2 RCT compared the survival effects of dispatcher CPR instruction consisting of chest compression alone or chest compression with rescue breathing
  • There was a lower risk of death after adjustment for confounders (adjusted hazard ratio 0.91, 95% confidence interval 0.83-0.99, p=0.02)
  • Findings strongly support a long-term mortality benefit of dispatcher CPR instruction strategy consisting of chest compression alone rather than chest compression plus rescue breathing

 

Show References



Category: Pharmacology & Therapeutics

Title: Lidocaine after IO Line Placement

Keywords: lidocaine, intraosseus, IO (PubMed Search)

Posted: 1/2/2013 by Bryan Hayes, PharmD (Emailed: 2/2/2013) (Updated: 2/2/2013)
Click here to contact Bryan Hayes, PharmD

Intraosseus (IO) access has become quite popular in critically ill patients requiring immediate resuscitation. In a patient responsive to pain, however, pain and discomfort is associated with the force of high-volume infusion through the established line.

  • Before flushing the line, consider administering preservative-free 2% lidocaine (without epinephrine) for patients responsive to pain prior to flush.

  • The suggested dose is 20-40 mg (1-2 mL) of the 2% lidocaine, followed by the 10 mL saline flush.

If preservative-free 2% lidocaine is not stocked in your ED, now is the time to consider adding it.

Show References